Horizon Pharma plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Horizon Pharma plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketlines Horizon Pharma plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Horizon Pharma plc since January2007.

Synopsis

Marketlines Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Horizon Pharma plcs contact information and business Summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Horizon Pharma plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Horizon Pharma plcs M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Horizon Pharma plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Horizon Pharma plcs financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Horizon Pharma plcs growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors business structure and growth strategies.


COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
--Mergers and Acquisitions - Overview
--Mergers and Acquisitions - Deal reports
PARTNERSHIP
--Partnership - Overview
--Partnership - Deal reports
CAPITAL RAISING
--Capital Raising - Overview
--Capital Raising - Deal reports

APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center

List Of Tables



--Horizon Pharma plc activity by deal type - volume (2013 -YTD2017)
--Horizon Pharma plc M&A average deal size - value ($m) (2013 -YTD2017)
--Horizon Pharma plc legal advisor ranking by value ($m)
--Horizon Pharma plc financial advisor ranking by value ($m)
--Top Deals(2013 -YTD2017)
--Horizon Pharma plc targets and partners (2013 -YTD2017)
--Horizon Pharma plc M&A volume and value trend (2013-YTD2017)
--Horizon Pharma plc M&A activity by geography (2013-YTD2017)
--Horizon Pharma plc partnership volume and value trend (2013-YTD2017)
--Horizon Pharma plc partnership trend by key deal type (2013-YTD2017)
--Horizon Pharma plc capital raising volume and value trend (2013-YTD2017)
--Horizon Pharma plc capital raising by deal type (2013-YTD2017)

List Of Figures



--Horizon Pharma plc activity by deal type - volume (2013-YTD2017)
--Horizon Pharma plc M&A average deal size - value ($m)
--Horizon Pharma plc M&A volume and value trend (2013-YTD2017)
--Horizon Pharma plc M&A activity by geography (2013-YTD2017)
--Horizon Pharma plc partnership volume and value trend (2013-YTD2017)
--Horizon Pharma plc partnership trend by key deal type (2013-YTD2017)
--Horizon Pharma plc capital raising volume and value trend (2013-YTD2017)
--Horizon Pharma plc capital raising by deal type (2013-YTD2017)

Horizon Therapeutics Plc (HZNP) - Financial and Strategic SWOT Analysis Review

Horizon Therapeutics Plc (HZNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

2017 US Cell Surface Marker Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

Complete report $2,250.  DataPack (test volumes, sales forecasts, supplier shares) $1,450.RationaleThe use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages,

USD 2250 View Report

Verona Pharma Plc (VRNA) - Financial and Strategic SWOT Analysis Review

Verona Pharma Plc (VRNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Immupharma Plc (IMM) - Financial and Strategic SWOT Analysis Review

Immupharma Plc (IMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available